Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)Immunology Published on 2020-06-192022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] Administered Antiviral antiviral action antiviral property Ascorbate ascorbic acid caused convalescent plasma coronavirus COVID-19 COVID-19 patient Critically ill death develop Efficacy Evidence flavonoids Health healthcare high-risk population immune system immunomodulatory property Immunonutrition imperative Intervention investigated overlapping pandemic pharmacological agent pharmacological treatment prevention Prophylaxis quercetin respiratory SARS-CoV-2 shown Stress synergistic the disease Treatment Vitamin Vitamin C [DOI] 10.3389/fimmu.2020.01451 PMC 바로가기 [Article Type] Immunology
Drug repositioning is an alternative for the treatment of coronavirus COVID-19Research article Published on 2020-06-012022-10-05 Journal: International journal of antimicrobial agents [Category] SARS, 신약개발, 치료법, 치료제, [키워드] caused coronavirus COVID-19 COVID-19 disease drug extreme pandemic pharmacological treatment raised repositioning SARS-CoV SARS-CoV-2 therapeutic Treatment [DOI] 10.1016/j.ijantimicag.2020.105969 [Article Type] Research article
The Rationale for Potential Pharmacotherapy of COVID-19Review Published on 2020-05-142022-10-28 Journal: Pharmaceuticals [Category] COVID-19, [키워드] ACE2 active against addition Antiviral Baricitinib Care cause Chloroquine clinical care Clinical management clinical trial clinical trials Clinical use Compound computational analysis Consensus coronavirus disease coronavirus epidemics Coronavirus infection coronavirus SARS-CoV-2 COVID-19 COVID-19 patient COVID-19 patients defined effective Epidemiology Evidence Favipiravir Health include increasingly Infection interferons investigated Lopinavir medication MERS-CoV Middle East molecular biology technique other disease pandemic pharmacological treatment pharmacotherapy Potential potential therapies professional Randomized rationale Remdesivir respiratory syndrome coronavirus SARS-CoV SARS-CoV-2 shown Spread Standard of care suggested tested Therapies therapy TMPRSS2 virus World Health Organization Wuhan, China [DOI] 10.3390/ph13050096 PMC 바로가기 [Article Type] Review
A brief review of the latest pharmacological treatments of COVID-19Review Article Published on 2020-01-012022-10-31 Journal: Caspian Journal of Internal Medicine [Category] COVID-19, [키워드] 2019-nCoV article cause China Community Complete COVID-19 disease drug effective Healthcare system knowledge mechanism New Pathogenesis pharmacological pharmacological treatment Pneumonia problem SARS-CoV-2 Treatment treatments of COVID-19 Vaccine virus virus spread Wuhan [DOI] 10.22088/cjim.11.0.460 PMC 바로가기 [Article Type] Review Article
Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and TisiologySpecial Article Published on 2020-01-012022-10-29 Journal: Revista Brasileira de Terapia Intensiva [Category] COVID-19, [키워드] anticoagulation Bacterial Betacoronavirus Brasil Brazil Chloroquine clinical trials conducted Coronavirus infections/drug therapy Corticosteroids COVID-19 Diretrizes effective Effectiveness Evidence GRADE guideline guidelines hospitalized patients Infecções por coronavirus/tratamento farmacológico Infectious disease Influenza information Interpretation Intervention Medicine methodologist oseltamivir Patient pharmacological pharmacological treatment professional provided Pulmonology Rapid recommendation Result Safe SARS-CoV-2 Society systematic reviews Therapies therapy Tocilizumab treated Treatment use of hydroxychloroquine was performed [DOI] 10.5935/0103-507X.20200039 PMC 바로가기 [Article Type] Special Article